GSK recalls 600,000 Ventolin Inhalers from US
Multinational pharmaceutical company, GlaxoSmithKline (GSK) has announced the recall of over 590,000 Salbutamol (Ventolin) inhalers from the US market, saying there could be issues with the delivery technique.
The recall is for three lots of Ventolin HFA 200D inhalers with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848.
The inhalers, according to reports, have been distributed to hospitals, pharmacies, retailers and wholesalers in the United States.
“There is attainable risk that the affected inhalers could potentially not deliver the stated number of actuations,” according to GSK spokesman Juan Carlos Molina. “We continue to investigate the situation in order to identify the root lead to and implement appropriate corrective and preventative actions.”
The recall is not directed at individuals, but those with inhalers from the recalled lots have been advised to contact the company.
About author
You might also like
CSM situation report in states
… Zamfara leads with 2, 337 cases, 262 deaths As at April 5, 2017, Zamfara State reported the highest number of Cerebrospinal meningitis (CSM) cases, put at 2,337 with 262
WHO backs mask-wearing on long flights
Omicron variant spreads in U.S. World Health Oranisation (WHO) on Tuesday advised that countries should consider recommending passengers wear masks on long haul flights. WHO said this was to counter
Sanofi steps up campaign against thrombosis
In an unprecedented move to combat the growing incidence of death due to venous thromboembolism (VTE) in Nigeria, multinational pharmaceutical company, Sanofi, on Wednesday October 23, organized a scientific conference aimed at
0 Comments
No Comments Yet!
You can be first to comment this post!